HTS Libraries Products & Reviews

Recombinant or purified CA19-9 antigen, a sialylated Lewis blood group antigen, which is a widely used serum biomarker for pancreatic and gastrointestinal cancers.

High-purity proteins produced through genetic engineering in heterologous expression systems, ensuring consistency, scalability, and reduced lot-to-lot variability for research and development.

Recombinant Human Programmed Death-Ligand 1 (PD-L1/CD274/B7-H1), the primary ligand for PD-1, expressed on tumor and immune cells to suppress anti-tumor immunity.

Recombinant Human Bone Morphogenetic Protein 7 (BMP-7), a TGF-β superfamily member that induces bone and cartilage formation and plays roles in renal development and repair.

Recombinant Human Bone Morphogenetic Protein 2 (BMP-2), a key regulatory protein that induces bone and cartilage formation, used extensively in orthopedics and stem cell differentiation.

Recombinant Human Apolipoprotein E (ApoE), a key protein in lipid metabolism that plays a central role in cardiovascular health and Alzheimer's disease pathogenesis.

Recombinant Human B-cell lymphoma 2 (BCL-2) protein, a key regulator of apoptosis (programmed cell death) and a well-established oncoprotein in many cancers.

Recombinant Human B-cell Antigen Receptor Complex-associated protein alpha chain (CD79A), a essential component of the B-cell receptor (BCR) and a marker for B-cell lineage.

A recombinant B-lymphocyte surface antigen, CD19, which is a pivotal target for immunotherapy in B-cell malignancies, including CAR-T cell and antibody-based therapies.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.

A portfolio of recombinant immunoglobulins and cell surface proteins serving as critical targets for the development and functional validation of Chimeric Antigen Receptor T-cell (CAR-T) therapies.

Recombinant Human Leukocyte Antigen G (HLA-G), a non-classical MHC class I molecule involved in immune tolerance at the maternal-fetal interface and in immune evasion by tumors.

Recombinant Human Fibroblast Growth Factor 2 (Basic FGF), a potent mitogen and morphogen for a wide range of mesoderm and neuroectoderm-derived cells in culture.

Recombinant Human Erythropoietin (EPO), the primary hormone regulating red blood cell production (erythropoiesis), used in research and as a therapeutic for anemia.

Recombinant Human Programmed Cell Death Protein 1 (PD-1/CD279), a critical immune checkpoint receptor that suppresses T-cell activation and is a major target in cancer immunotherapy.

ACRO has developed a full range of full-length multi-pass transmembrane proteins with stabilized structure and high activity including CD20, Claudin18.2, CD133, GPRC5D, CXCR4, CCR5 and CCR8.

ACROBiosystems offers a comprehensive collection of recombinant Fc receptor proteins including FcRn FcγRs, FcεRs to expedite antibody drug development and research programs.

Proteins for neuroscience, TAU protein

Proteins for neuroscience, Alpha-Synuclein protein

IL-2 protein and IL-2 receptor proteins

Vapourtec offers a range of world class peptide synthesizer systems offering fast flow solid phase peptide synthesis from 0.05 mmol to 30 mmol.

The LlaVHHL-2 Llama Naïve Single Domain Antibody Library is a state-of-the-art resource for efficient, high-quality antibody screening. Designed to meet the diverse needs of researchers, this library provides access to a rich pool of sdAbs derived from llama naïve antibody genes.

The Phage Display AlVHHL-2 Alpaca Single Domain Antibody Library excels due to its vast library size and significant genetic variety produced from multiple alpacas. The combination of broad genetic diversity and single-domain antibodies delivers precise solutions for complex scientific challenges that standard antibody libraries find difficult to address.

Creative Biolabs provides screening services for the CaVHHL-S2 Camel Synthetic Single Domain Antibody Library but does not sell the library directly. Our advanced M13 pIII fusion phage display technology combined with high-throughput screening platforms enables clients to rapidly identify ideal antibody candidates while resolving issues like extended screening durations and the detection of low-affinity antibodies.

Recombinant Human B-cell Maturation Antigen (BCMA/TNFRSF17), a TNF receptor superfamily member that is a clinically validated target for multiple myeloma therapies.